Medications

FDA panel narrowly backs DNA colon cancer test

A panel of Food and Drug Administration advisers has narrowly backed an experimental blood test that uses patients' DNA to help screen for colon cancer.

Oncology & Cancer

Bone turnover markers predict prostate cancer outcomes

Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Their study, published online in the ...

Oncology & Cancer

New marker identified for early diagnosis of lung cancer

A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical ...

Oncology & Cancer

New screening strategy may catch ovarian cancer at early stages

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...

Oncology & Cancer

Source of tumor growth in aggressive prostate cancer found

Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The ...

page 9 from 21